Celera Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 10 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 M
- Revenue Growth -21.33%
- Profit Growth -44.69%
- Ebitda 1.55%
- Net Worth 9.78%
- Total Assets 2.96%
About Celera Healthcare
Celera Healthcare Private Limited (CHPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 August 2014 and has a history of Ten years and five months. Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹4.00 M.
Neeraj Saxena and Deepak Bakshi serve as directors at the Company.
Company Details
-
Location
Lucknow, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74120UP2014PTC065750
-
Company No.
065750
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Aug 2014
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
What products or services does Celera Healthcare Private Limited offer?
Celera Healthcare Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules.
Who are the key members and board of directors at Celera Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Bakshi
|
Director | 21-Mar-2016 | Current |
|
Neeraj Saxena
|
Director | 29-Aug-2014 | Current |
Financial Performance of Celera Healthcare.
Celera Healthcare Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 21.33% decrease. The company also saw a substantial fall in profitability, with a 44.69% decrease in profit. The company's net worth moved up by a moderate rise of 9.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Celera Healthcare?
In 2021, Celera Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹4.00 M
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 0.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Sep 2022 | Canara Bank | ₹2.50 M | Open |
| 14 Jul 2020 | Canara Bank | ₹1.50 M | Open |
How Many Employees Work at Celera Healthcare?
Unlock and access historical data on people associated with Celera Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Celera Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Celera Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
